Original filing (PDF)20231002120919NAL0035087906001

Oncomyx Therapeutics

Name: Oncomyx Therapeutics — Oncomyx Therapeutics 401(k), Form 5500 (2022)
Creator: Oncomyx Therapeutics
License: https://www.usa.gov/government-works

Form 5500-SF

FILING_RECEIVED

Oncomyx Therapeutics 401(k) Plan

401(k) retirement plan · Oncomyx Therapeutics' Oncomyx Therapeutics 401(k) Plan filed a Form 5500 for plan year 2022.

Active participants

Accounts w/ balance

Plan assets (EOY)

Net assets (EOY)

People on this filing

Bruce Campbell signed Oncomyx Therapeutics' 2022 Form 5500 as plan administrator.

Bruce Campbell — Plan Administrator — Form 5500 signer

Get verified email & phone for these signers

Signer names are public record from the Form 5500 e-signature.

Plan identifiers

Oncomyx Therapeutics' EIN is 83-2289356.

EIN 83-2289356

Plan number 001

Plan year 2022

ACK ID 20231002120919NAL0035087906001

Official Form 5500 document

Download the official 2022 Form 5500 (PDF) for Oncomyx Therapeutics from the U.S. Department of Labor's EFAST2 system.

Download the official 2022 Form 5500 (PDF)

Plan features

Oncomyx Therapeutics' plan includes profit-sharing, a 401(k) feature, ERISA 404(c) participant direction, a default investment (QDIA).

Decision-maker contacts

One unlock reveals every key decision-maker — plan signer, CFO, HR & Benefits — with verified email + LinkedIn for ONCOMYX THERAPEUTICS.

Finding similar companies…

Plan health score

Top-tier plan health

Directional indicator from public Form 5500 data — compliance & integrity, total plan cost, participant health and vendor stack, benchmarked against same-size peers. Not a fiduciary tool. Based on 50% of scoring inputs for this filing.

Compliance & integrity

100

Total plan cost

n/a

Plan health

n/a

Vendor & structure

100

Helping the score